Continuing Education Activities
Here at JADPRO CE, you can find a valuable array of certified educational opportunities: it’s the place to get your credits and update your learning in oncology. We provide advanced practitioners like you with a wide range of continuing education, covering the most current topics in several formats so you can choose the way you want to learn. You'll find that our CE offerings are easy to navigate. You can sort by topic and/or format, or simply browse the site and get started!
Approaches for Optimal Molecular Testing, Treatment, and Management of NSCLC and Accompanying Driver Mutations
Posted: October 18, 2021 / Expires: December 31, 2022
Estimated time to complete: 1.25 hours
CLL/SLL: Managing Adverse Events Associated with BTK Inhibitor Therapy
Posted: October 18, 2021 / Expires: December 31, 2022
Estimated time to complete: 1.25 hours
Navigating the Expanding Treatment Landscape in Metastatic Urothelial Cancer: Novel Targeted Therapies
Posted: October 18, 2021 / Expires: December 31, 2022
Estimated time to complete: 1.25 hours
Navigating the Evolving Treatment Landscape in Prostate Cancer: A Focus on Novel Anti-androgen Therapy
Posted: October 18, 2021 / Expires: December 31, 2022
Estimated time to complete: 1.25 hours
Metastatic HER2-Positive Breast Cancer: Newer and Emerging Treatment Considerations and Personalized Therapies
Posted: October 18, 2021 / Expires: December 31, 2022
Estimated time to complete: 1.25 hours
Advanced Practice Perspectives on Preventing and Managing Tumor Lysis Syndrome and Neutropenia in Chronic Lymphocytic Leukemia
Tumor lysis syndrome and neutropenia can be life-threatening toxicities of therapies for chronic lymphocytic leukemia. This article focuses on risk assessment, prophylaxis, early identification, monitoring, patient education, and prompt intervention to reduce the risk of these complications.
Posted: January 20, 2021 / Expires: January 19, 2022
Estimated time to complete: 0.5 hour
Clinical Updates in Acute Kidney Injury: Improving Outcomes for Patients Treated with High-Dose Methotrexate
In this CE/CME-certified activity, you'll find a case-based interactive module on the safe and effective use of approved therapies to manage acute kidney injury associated with high-dose methotrexate.
Posted: December 09, 2020 / Expires: December 08, 2022
Estimated time to complete: 0.5 hour
CDK4/6 Inhibitors: Paving the Way for HR-Positive, HER2-Negative Early Breast Cancer
This activity will review the latest emerging evidence for CDK4/6 inhibitors in the adjuvant setting for early breast cancer. Interprofessional perspectives and recommendations for improving adherence and side effect management will be featured.
Posted: November 17, 2021 / Expires: November 16, 2022
Estimated time to complete: 0.5 hour